| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8819664 | Journal of Cystic Fibrosis | 2018 | 7 Pages |
Abstract
The short-term impact of ivacaftor therapy on sputum microbiota composition in patients with G551D mutations are modest compared to those resulting from antibiotic exposure, and may be masked by changes in antibiotic treatment regimen.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Anton Y. Peleg, Jocelyn M. Choo, Katherine M. Langan, Deirdre Edgeworth, Dominic Keating, John Wilson, Geraint B. Rogers, Tom Kotsimbos,